1Wright Browne V, McClain KL, Talpaz M et al. Physiology and pathophysiology of dendritic cells. Hum Pathol. 1997.28:563
2Thomas R, Davis LS, Lipsky PE. Isolation and characterization of human peripheral blood dendritic cells. J Immunol 1993,150:821
3Olweus J, BitMansour A, Warnke R et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA, 1997,94:12551
4Borkowski TA, Letterio TJ, Farr AG et al. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1null mice is devoid of epidermal Langerhans cells. J Exp Med, 1996,184:2417
5Palucka KA, Taquet N, Sanchez Chapuis F et al. Dendritic cells as the terminal stage of monocyte differentiation. J Immunol, 1998,160:4587
6Mayordomo JI, lorina T, Storkus WJ et al. Bone marrowderived dendritic cells serve as potent adjuvants for peptidebased antitumor vaccines. Stem Cell, 1997,15(2):94
7Strobl H, Bello Fernandez C, Riedl E et al. Flt3-ligand in coorperation with transforming growth factor-β1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free condition. Blood, 1997,90(4): 1425
8Arrighi JF. Hauser C, Chapuis B et al. Long-term culture of human CD34 ( + ) progenitors with Flt3-ligand, thrompbopoietin, and stem cell factor induces extensive amplification of a CD34(-) CD14(-) and a CD34(-) CD14(+) dendritic cell precursor. Blood, 1999,93 (7): 2244
9Rosenzwajg M, Camus S, Guigon M et al. The influence of interleukin-4,-13, and Flt3-ligand on human dendritic cell differentiation from cord blood CD34 (+) progenitor cells.Exp Haematol, 1998,26:63
10Saraya K, Reid CD. Stem cell factor and the regulation of DC production from CD34 (+) progenitors in bone marrow and cord blood. Br J Haematol, 1996,93(2):258
2Suster S,Fisher C.Immunoreactivity for the human hematopoietic progenitor cell antigen(CD34)in lipomatous tumors[J].Am J Surg Pathol,1997,2(2):195-200.
3Feng B,Inaba M,Lian ZX.Development of mouse dendritic cell from lineage-negative c-kit ＜ low pluripotent hemopoietic stem cells in vitro[J].Stem cell,2000,11:53.
4Suster S, Fisher C.Immunoreactivity for the human hematopoietic progenitor cell antigen(CD34) in lipomatous tumors[J]. Am J Surg Pathol,1997,21(2):195-200.
5Graadt van Roggen JF, van Velthuysen ML,Hogendoorn PC.The histopathological differential diagnosis of gastrointestinal stromal tumors[J]. J Clin Pathol,2001,54(2):96-102.
6Biao F,Muneo I,Zhexiong L.Development of mouse dendritic cell from lineage negative c-kit (low) pluripotent hemopoietic stem cells in vitro[J].Stem cells,2000,18(1):53-60.
7Kindblom LG,Remotti HE,Aldenborg F, et al.Gastrointestinal pacemaker cell tumor (GIPACT):gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal[J]. Am J Pathol,1998,152(5):1259-1269.
8Perez-Ordonez B,Erlandson RA,Rosai J.Follicular dendritic cell tumor:report of 13 additional cases of a distinctive entity[J].Am J Surg Pathol,1996,20(8):944-955.
9Suster S,Fisher C,Moran CA.Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue,skin,serosal surfaces, and gastrointestinal tract[J].Am J Surg Pathol,1998,22(7):863-872.
10Rescigno M,Granucci F,Ricciardi-Castagnoli P.Dendritic cells at the end of the millennium[J]. Immunol Cell Biol,1999,77(5):404-410.
